Martin Baccardax

Baccardax, a former bond salesman who spent 8 years on the trading floor in Toronto and London, has worked in and around the global financial markets for more than 25 years, covering companies from birth in the bond markets to death in the bankruptcy courts -- and all points in between.
Following television stints with CNBC Europe in London, where he served as on-air Economics editor co-anchor of the Closing Bell program, Baccardax was named London Bureau Chief in October 2016.

Recent Articles By The Author

UK Lawmakers Reject Theresa May's Brexit Deal, Triggering April 12 EU Departure

UK Lawmakers Reject Theresa May's Brexit Deal, Triggering April 12 EU Departure

U.K. lawmakers voted for a third time to reject Prime Minister Theresa May's Withdrawal Agreement Friday, setting a path for Britain to leave the European Union without a bespoke deal on April 12.

Lyft Leads Pack of $50 Billion Planned IPOs as 'Decacorns' Gallop to Market

Lyft Leads Pack of $50 Billion Planned IPOs as 'Decacorns' Gallop to Market

Lyft will debut the biggest U.S. IPO in five years Friday as shares in the ride-hailing group open for trading on the Nasdaq in a move that could trigger a wave of more than $50 billion in new listings as so-called 'Unicorn' start-ups tap bullish investor sentiment.

Wells Fargo Slide as CEO Departs; 'About Damn Time' Says Elizabeth Warren

Wells Fargo Slide as CEO Departs; 'About Damn Time' Says Elizabeth Warren

Wells Fargo shares traded lower Friday after CEO Tim Sloan said he would step down after just three years at the helm as the bank attempts to put years of scandals and political criticism behind it by seeking an outsider to lead the fourth largest U.S. lender.

AstraZeneca Slides on $6.9 Billion Cancer Drug Deal with Japan's Daiichi Sankyo

AstraZeneca Slides on $6.9 Billion Cancer Drug Deal with Japan's Daiichi Sankyo

AstraZeneca shares traded near the bottom of the London market Friday after the drugmaker agreed a potential $6.9 billion deal with Japan's Daiichi Sankyo Co. to develop and market a breast and gastric cancer treatment over the coming years.

US Futures Gain in Best Quarter Since 2009 as Mnuchin Touts China Trade Progress

US Futures Gain in Best Quarter Since 2009 as Mnuchin Touts China Trade Progress

Global stocks traded higher Friday, lifting U.S. equity markets towards their best opening quarter gain in a decade, as investors crept back into risk markets amid progress in U.S.-China trade talks, modestly higher fixed income yields and the opening trade of the biggest IPO since 2014.

UK Lawmakers Face Yet Another Make-or-Break Vote as May Rolls Final Brexit Dice

UK Lawmakers Face Yet Another Make-or-Break Vote as May Rolls Final Brexit Dice

U.K. Prime Minister Theresa May will bring a watered-down version of her twice-defeated Withdrawal Agreement to Parliament Friday in what could be the final attempt to break the nation's crippling Brexit stalemate on the very day Britain had been scheduled to leave the European Union .

Five Below Tops Q4 Earnings Estimate, Sees Solid Comparable Spring Sales

Five Below Tops Q4 Earnings Estimate, Sees Solid Comparable Spring Sales

Five Below shares trade higher sharply Thursday after the discount retailer posts stronger-than-expected fourth-quarter earnings and forecast solid comparable-store sales heading into the spring season.

Accenture Rides Cloud to Q2 Earnings Beat as Bookings Hit Record $11.8 Billion

Accenture Rides Cloud to Q2 Earnings Beat as Bookings Hit Record $11.8 Billion

Accenture posts stronger-than-expected second-quarter earnings and boosts its full-year financial guidance thanks to the global consultancy group's ongoing drive into digital and cloud service investments.

Deutsche Bank Plays Down Capital Hike Report as Shares Slide in Frankfurt

Deutsche Bank Plays Down Capital Hike Report as Shares Slide in Frankfurt

Deutsche Bank move to downplay a report suggesting Germany's biggest lending was preparing a massive capital increase as part of a potential merger with domestic rival Commerzbank AG CRZBY, saying Thursday that no such discussions have taken place.

Lululemon Surges to Record High After Q4 Blowout, 2019 Earnings Forecast

Lululemon Surges to Record High After Q4 Blowout, 2019 Earnings Forecast

Lululemon Athletic shares opened at a record high Thursday after the sports apparel group posted solid fourth quarter earnings and said accelerating online sales would drive better-than-expected full year profits.